One multi-national study that analyzed data from 524 families with PALB2 PVs in 21 countries concluded that the estimated relative risk (RR) of breast cancer was 7.18 (95% CI, 5.82- 8.85; p=6.5×10-76) (69). The gene discussed is PALB2; the disease is breast carcinoma.